Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility.
暂无分享,去创建一个
T. Scheenen | J. Witjes | A. Heerschap | C. Hulsbergen-van de Kaa | J. Barentsz | S. Heijmink | S. Roell | B. Knipscheer | C. Hulsbergen–van de Kaa
[1] H. Huisman,et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.
[2] Dennis W J Klomp,et al. Optimal timing for in vivo 1H‐MR spectroscopic imaging of the human prostate at 3T , 2005, Magnetic resonance in medicine.
[3] F. Schick,et al. 3D proton MR spectroscopic imaging of prostate cancer using a standard spine coil at 1.5 T in clinical routine: a feasibility study , 2005, European Radiology.
[4] M. Kattan,et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.
[5] P. Carroll,et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. , 2004, Radiology.
[6] Dennis W J Klomp,et al. Initial Experience of 3 Tesla Endorectal Coil Magnetic Resonance Imaging and 1H-Spectroscopic Imaging of the Prostate , 2004, Investigative radiology.
[7] Mark A Brown,et al. Time‐domain combination of MR spectroscopy data acquired using phased‐array coils , 2004, Magnetic resonance in medicine.
[8] Mark Rijpkema,et al. Combined quantitative dynamic contrast‐enhanced MR imaging and 1H MR spectroscopic imaging of human prostate cancer , 2004, Journal of magnetic resonance imaging : JMRI.
[9] Arend Heerschap,et al. Fast acquisition‐weighted three‐dimensional proton MR spectroscopic imaging of the human prostate , 2004, Magnetic resonance in medicine.
[10] M. Graefen,et al. Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction. , 2003, European urology.
[11] Arend Heerschap,et al. Proton MR spectroscopy of prostatic tissue focused on the etection of spermine, a possible biomarker of malignant behavior in prostate cancer , 2000, Magnetic Resonance Materials in Physics, Biology and Medicine.
[12] H. Hricak,et al. Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging , 2000, Magnetic resonance in medicine.
[13] J. Kurhanewicz,et al. Improved water and lipid suppression for 3D PRESS CSI using rf band selective inversion with gradient dephasing (basing) , 1997, Magnetic resonance in medicine.
[14] A. Heerschap,et al. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. , 1997, Anticancer research.
[15] Michael Garwood,et al. Solvent Suppression Using Selective Echo Dephasing , 1996 .
[16] J R Thornbury,et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. , 1996, AJR. American journal of roentgenology.
[17] P. Carroll,et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.
[18] A. Wilman,et al. The response of the strongly coupled AB system of citrate to typical 1H MRS localization sequences. , 1995, Journal of magnetic resonance. Series B.
[19] J Kurhanewicz,et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. , 1995, Urology.
[20] A S Whittemore,et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.
[21] P. Bottomley. Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.
[22] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .